Skip to main content
Explore URMC

Cancer Control and Supportive Care

doctors at benchThe Cancer Control and Supportive Care research program focuses on reducing the prevalence of cancer- and treatment-related side effects and toxicities. Building on our success as one of the nation’s first cancer control and population science programs, we develop and conduct research in such areas as supportive care, exercise oncology, health disparities and geriatric oncology.

Working directly with patients, survivors and caregivers, Wilmot’s CCSC Program focuses its expertise and resources on the following specific aims:

  • Develop novel and effective treatments for the toxicities and side effects caused by cancer and its treatments among patients, survivors, and caregivers.
  • Identify the etiology and pathophysiology of toxicities and side effects and identify mechanisms of action whereby effective treatments mitigate toxicities and side effects.
  • Develop effective interventions for oncology treatment centers and health care systems to improve cancer care delivery and cancer outcomes.

PEAK lab

Program Leaders

MustianKaren Mustian, Ph.D., M.P.H.

Dean’s Professor of Surgery, Cancer Control

Dr. Mustian focuses on the role of physical activity and exercise on cancer- and treatment-related side effects.

MohileSupriya Mohile, M.D., M.S.

Philip and Marilyn Wehrheim Professor of Medicine, Hematology/Oncology

Dr. Mohile conducts research focused on improving cancer care delivery for older adults.